Cardiovascular Events, Conditions, and Procedures Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study-Reference-Cited by-同舟云学术

Cardiovascular Events, Conditions, and Procedures Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study

Published:2016-11-12 Issue:1 Volume:57 Page:31-44
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:Headache: The Journal of Head and Face Pain

Author:

Buse Dawn C.¹,Reed Michael L.²,Fanning Kristina M.²,Kurth Tobias³,Lipton Richard B.⁴

Affiliation:

1. Department of Neurology; Albert Einstein College of Medicine and Montefiore Headache Center; Bronx NY USA

2. Vedanta Research; Chapel Hill NC USA

3. Department of Epidemiology and Population Health; Albert Einstein College of Medicine; Bronx NY, USA

4. Institute of Public Health, Charité - Universitätsmedizin Berlin; Germany

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/head.12962/fullpdf

Reference30 articles.

1. Migraine and risk of cardiovascular disease in men;Kurth;Arch Intern Med.,2007

2. Migraine and risk of cardiovascular disease in women;Kurth;JAMA.,2006

3. Migraine and cardiovascular disease: Systematic review and meta-analysis;Schürks;BMJ.,2009

4. Triptan use as a function of cardiovascular risk. A population-based study;Bigal;Headache.,2010

5. Migraine and cardiovascular disease: A population-based study;Bigal;Neurology.,2010

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of Triptans in Patients Who Have or Are at High Risk for Cardiovascular Disease;Mayo Clinic Proceedings;2024-08

2. Long-term safety of zavegepant nasal spray for the acute treatment of migraine: A phase 2/3 open-label study;Cephalalgia;2024-08

3. Cardiovascular safety of dihydroergotamine mesylate delivered by precision olfactory delivery (INP104) for the acute treatment of migraine;Headache: The Journal of Head and Face Pain;2024-05-27

4. Cost-effectiveness of rimegepant oral lyophilisate compared to best supportive care for the acute treatment of migraine in the UK;Journal of Medical Economics;2024-04-27

5. The Role of the Combination Paracetamol/Caffeine in Treatment of Acute Migraine Pain: A Narrative Review;Pain and Therapy;2024-03-06